Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.44007 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.36677 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.36987 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.30423 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.28696 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.41462 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.44552 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.3373 | 54 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.3002 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.35565 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.35553 | 55 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.34397 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.37293 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.36005 | 55 |